Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

2011 Archived Teen Vaccination Coverage

National Immunization Survey (NIS) – Teen

2010 Archived Teen Vaccination Coverage


Key Points

The 2011 NIS-Teen coverage data show that national vaccination rates in adolescents aged 13 through 17 years have continued to improve for tetanus-diphtheria-pertussis (Tdap) vaccine and for meningococcal conjugate vaccine.

2012 HPV Vaccination Coverage for Girls

2012 HPV Vaccination Coverage for Girls.

The newest data showing coverage rates of HPV vaccine for girls 13-17 years of age were published July 25, 2013 in MMWR.

More

National Tdap coverage rates for teens 13 through 15 years old met the Healthy People 2020 objective of 80 percent for the first time.

For the third year in a row however, the increase in coverage for human papillomavirus (HPV) vaccine is half of the increases seen for Tdap and meningococcal vaccine coverage. 

HPV vaccine coverage rates are lower for younger girls, which tells us that girls are not receiving the HPV vaccine series at the recommended ages of 11 or 12 years.

Geographic disparities were evident in HPV vaccination, with southeastern U.S. states having lower rates than elsewhere.  These states also have higher rates of cervical cancer.

Top of Page

NIS-Teen Survey Data Collected in 2011

Tdap Vaccine

  • Nationally, Tdap increased by 9 percentage points reaching about 78 percent (68.7% in 2010 v. 78.2% in 2011).
  • Coverage for one dose of Tdap was lower for those living below poverty.

Meningococcal Conjugate Vaccine

  • Meningococcal conjugate vaccine increased by nearly 8 percentage points to about 71 percent (62.7% in 2010 v. 70.5% in 2011).
  • Coverage for one dose of meningococcal conjugate vaccine was higher among Hispanics than whites.

HPV Vaccine

  • For girls who received at least one dose of HPV vaccine, coverage increased by 4 percentage points to 53 percent (48.7% in 2010 v 53.0% in 2011).
    • Receipt of three doses increased by 3 percentage points to 35 percent (32.0% in 2010 v. 34.8% in 2011).
    • Of the girls who started the series, and had adequate time to complete the series before the NIS-Teen interview date, about 29 percent did not receive all three recommended doses.
    • HPV vaccination rates were lower among younger girls compared to older girls.
    • The receipt of three HPV doses among those who had adequate time to complete the series before the interview date was lower among blacks than whites.
    • The receipt of one or three HPV doses among was lower among whites than Hispanics.
    • Completion of the 3 dose HPV series among those who had adequate time to complete the series before the interview date was lower for those living below poverty.
  • For boys who received at least one dose of HPV vaccine, coverage increased by 7 percentage points to about 8 percent (1.4% in 2010 v. 8.3% in 2011).
    • Receipt of three doses is 1 percent.
    • Of the boys who began the series and had adequate time to finish the series before the NIS-Teen interview date, 28 percent completed the series.
 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #